A multicenter investigation into the occurrence of high-pressure excursions

Journal of Extra-Corporeal Technology

Volumn 35, Issue 2, 2003, Pages 127-132

  Myers, Gerard J ^a   Weighell, Patrick R ^a   McCloskey, Brian J ^b   Holt, Alison M ^b   McTeer, Scott ^c   Maxwell, Sandy L ^c  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

^c University Hospital   (Canada)

Author keywords

Coronary artery bypass graft (CABG); Diprivan; Oxygenator; Platelets; Premembrane; Pressure excursion; Resistance; Thrombosis; Von Willebrand

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANESTHETIC AGENT; ANTICOAGULANT AGENT; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HETASTARCH; NORMOSOL; PLASMALYTE A; PROPOFOL; STREPTOKINASE; TRANEXAMIC ACID; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD GROUP TYPING; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CRYSTALLOID; EXTRACORPOREAL OXYGENATION; FEMALE; HEMATOLOGICAL PARAMETERS; HIGH PRESSURE EXCURSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEMBRANE; MULTICENTER STUDY; OXYGENATOR; PARTIAL THROMBOPLASTIN TIME; PRESSURE MEASUREMENT; PROTHROMBIN TIME; THROMBOCYTE; THROMBOSIS; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

EID: 0042267900     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Stoney WS, Alford WC, Burrus GR, et al. Air embolism and other accidents using pump oxygenators. Ann Thorac Surg. 1980;29:336-40.
2. Henderson, M., MacDonald, J., Mayer, R. et al: Platelet count reduction during cardiopulmonary bypass: a membrane comparison study. Proceed Can Soc Clin Perfusion. 1992;10:25-9.
3. Blomback M, Kronlund P, Aberg B, et al. Pathologic fibrin formation and cold induced clotting of membrane oxygenators during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1995;9:34-43.
4. Bearss, MG, Ericson, D, Parks, PJ et al: The puzzling case of the cryoprecipitates. AmSECT Today. 1996;6:21-5.
5. Palanzo DA, Zarro DL, Manley NJ, et al. Effects of Carmeda Bioactive surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass. Perfusion. 2001;16:279-83.
6. Wendel HP, Philipp A, Weber N, et al. Oxygenator Thrombosis: worst case after development of an abnormal pressure gradient incidence and pathway. Perfusion. 2001;16:271-8.
7. Myers, GJ, Legare, JF, Sullivan, JA et al: The use of autologous blood as part of the perfusate for cardiopulmonary bypass: A priming technique Perfusion. 2002;17:211-6.
8. Myers GJ. An update on perfusate composition. Proceed Mechanisms of Perfusion XIII 1998.
9. Schaadt J. Oxygenator Thrombosis: an international phenomenon. Perfusion. 1999;14:425-35.
10. Wahba A, Philipp BS, Behr R, et al. Heparin coated equipment reduces the risk of oxygenator failure. Ann Thorac Surg. 1998;65:1310-2.
11. Miller, MJ, Aniuk, L, McAdoo, S: The Multifactorial Aspects of Biocompatibility Proceed Can Soc Clin Perf. 1998
12. Myers GJ, Johnstone RJ, Swyer WJ, et al. Evaluation of Phosphorylcholine (Mimesys) coated Monolyth oxygenators during cardiopulmonary bypass in adults. J Extra Corp Tech. 2003;35:6-12.
13. De Somer F, Foubert L, Schacht E, et al. Nitric oxide donors attenuate increase in pressure drop across membrane oxygenators. Perfusion. 1999;14:331-6.
14. Wendel HP, Ziemer G. Coating techniques to improve the biocompatibility of artificial devices used for extracorporeal. Eur J Cardiothorac Surg. 1999;16:342-50.
15. He S, Cao H, Magnusson CG, et al. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843 Met of the von Willebrand factor protein. Thromb Res. 2001;103:241-8.
16. Di Bitondo R, Cameron CL, Daly ME, et al. The 1185 A/G and 1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction. Br J Haematol. 2001;115:701-6.
17. Bromberg M, Nygren H. Von Willebrand factor, a key protein in the exposure of CD62P on platelets. Biomaterials. 2001;22:2403-9.
18. Ruggeri ZM, Zimmerman TS. Von Willebrand factor and von Willebrand disease. Blood. 1987;70:895-904.
19. Aniuk, L, Miller, M, McAdoo, S et al: The phenomenon of pressure excursion ("Oxygenator Vasoconstriction"). Proceed Am Acad Cardiovasc Perf. 1999;20.
20. Luckras H, Boolauky D, Mohangee A. Cryofibrinogination: did it really happen? Perfusion. 2001;16:83-6.
21. Diprivan 1%: Product Monograph Zeneca Pharma, Inc. Mississauga, Ontario 1996.
22. Nader-Djalal N, Khadra WZ, Spaulding W, et al. Does Propofol alter the gas exchange in membrane oxygenators? Ann Thorac Surg. 1998;66:298-9.
23. Altmayer P, Buch U, Buch HP. Propofol binding to human blood proteins Arzneimittelforschung. 1995;45:1053-6.
24. Mazoit JX, Samii K. Binding of Propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Pharmacol. 1999;47:35-42.
25. Hammaren E, Rosenberg PH, Hynynen M. Coating of extracorporeal circuit with heparin does not prevent sequestration of Propofol in vitro. Br J Anesth. 1999;82:38-40.
26. Hynynen M, Hammaren E, Rosenberg PH. Propofol sequestration within the extracorporeal circuit. Can J Anesth. 1994;41:583-8.
27. Su HB, Tseng CC, Jenn CT, et al. Changes in Propofol levels in isolated cardiopulmonary bypass circuit. Acta Anaesthesiol Sin. 1996;34:17-20.